Goldman Sachs reported strong Q2 earnings driven by the AI investment cycle, featuring a 39.5% revenue increase and a 92% surge in EPS. In response to these results, analysts raised price targets for GS stock as the bank increased dividends by 11.1% and executed $4 billion in share buybacks. While the Platform Solutions segment faced headwinds from Apple Card loan markdowns, the bank also adjusted price targets for other entities like Regeneron Pharmaceuticals following the broader market performance.
Goldman Sachs adjusts Regeneron's target while KBW raises Truist Financial's outlook following a strong Q2 earnings beat.
Read the full storyThe bank reported a 39.5% revenue jump driven by investment banking strength, despite headwinds from Apple Card loan markdowns.
Goldman Sachs reported strong Q2 earnings exceeding estimates, as the AI investment cycle and a recovery in dealmaking drove record financial results.